Search research articles
Contact Us
Filters
Showing results (461-470 of 604) with videos related to
Page
of 61
Sort By:
JCO Clinical Cancer Informatics
|
April 21, 2023
Novel Approaches for Dynamic Visualization of Adverse Event Data in Oncology Clinical Trials: A Case Study Using Immunotherapy Trial S1400-I (SWOG)
Shing M Lee, Weijia Fan, Aijin Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2000
Interferon alpha consolidation after intensive chemotherapy does not prolong the progression-free survival of patients with low-grade non-Hodgkin's lymphoma: results of the Southwest Oncology Group randomized phase III study 8809
R I Fisher, B W Dana, M LeBlanc, et al.
Journal of the National Cancer Institute
|
February 25, 2021
Patient-Reported Outcomes and Long-Term Nonadherence to Aromatase Inhibitors
Dawn L Hershman, Alfred I Neugut, Anna Moseley, et al.
Sleep Medicine
|
May 1, 2012
DTI reveals hypothalamic and brainstem white matter lesions in patients with idiopathic narcolepsy
K Menzler, M Belke, M M Unger, et al.
JAMA Oncology
|
January 1, 2016
Adverse Health Events Following Intermittent and Continuous Androgen Deprivation in Patients With Metastatic Prostate Cancer
Dawn L Hershman, Joseph M Unger, Jason D Wright, et al.
Plos One
|
October 22, 2014
Tenfibgen ligand nanoencapsulation delivers bi-functional anti-CK2 RNAi oligomer to key sites for prostate cancer targeting using human xenograft tumors in mice
Janeen H Trembley, Gretchen M Unger, Vicci L Korman, et al.
Blood
|
May 10, 2003
A phase 2 trial of CHOP chemotherapy followed by tositumomab/iodine I 131 tositumomab for previously untreated follicular non-Hodgkin lymphoma: Southwest Oncology Group Protocol S9911
Oliver W Press, Joseph M Unger, Rita M Braziel, et al.
In Vitro Cellular & Developmental Biology. Animal
|
March 6, 2009
Lectin binding patterns reflect the phenotypic status of in vitro chondrocyte models
S Toegel, V E Plattner, S Q Wu, et al.
JAMA Network Open
|
November 11, 2022
Comparison of Acupuncture vs Sham Acupuncture or Waiting List Control in the Treatment of Aromatase Inhibitor-Related Joint Pain: A Randomized Clinical Trial
Dawn L Hershman, Joseph M Unger, Heather Greenlee, et al.
In Vivo (Athens, Greece)
|
December 28, 2000
Tumor blood supply and tumor localization by adoptively transferred IL-2 activated natural killer cells
U Nannmark, M E Hokland, R Agger, et al.
Page
of 61
Search research articles
Search
Showing results (461-470 of 604) with videos related to
Sort By:
Page
of 61
JCO Clinical Cancer Informatics
|
April 21, 2023
Novel Approaches for Dynamic Visualization of Adverse Event Data in Oncology Clinical Trials: A Case Study Using Immunotherapy Trial S1400-I (SWOG)
Shing M Lee, Weijia Fan, Aijin Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2000
Interferon alpha consolidation after intensive chemotherapy does not prolong the progression-free survival of patients with low-grade non-Hodgkin's lymphoma: results of the Southwest Oncology Group randomized phase III study 8809
R I Fisher, B W Dana, M LeBlanc, et al.
Journal of the National Cancer Institute
|
February 25, 2021
Patient-Reported Outcomes and Long-Term Nonadherence to Aromatase Inhibitors
Dawn L Hershman, Alfred I Neugut, Anna Moseley, et al.
Sleep Medicine
|
May 1, 2012
DTI reveals hypothalamic and brainstem white matter lesions in patients with idiopathic narcolepsy
K Menzler, M Belke, M M Unger, et al.
JAMA Oncology
|
January 1, 2016
Adverse Health Events Following Intermittent and Continuous Androgen Deprivation in Patients With Metastatic Prostate Cancer
Dawn L Hershman, Joseph M Unger, Jason D Wright, et al.
Plos One
|
October 22, 2014
Tenfibgen ligand nanoencapsulation delivers bi-functional anti-CK2 RNAi oligomer to key sites for prostate cancer targeting using human xenograft tumors in mice
Janeen H Trembley, Gretchen M Unger, Vicci L Korman, et al.
Blood
|
May 10, 2003
A phase 2 trial of CHOP chemotherapy followed by tositumomab/iodine I 131 tositumomab for previously untreated follicular non-Hodgkin lymphoma: Southwest Oncology Group Protocol S9911
Oliver W Press, Joseph M Unger, Rita M Braziel, et al.
In Vitro Cellular & Developmental Biology. Animal
|
March 6, 2009
Lectin binding patterns reflect the phenotypic status of in vitro chondrocyte models
S Toegel, V E Plattner, S Q Wu, et al.
JAMA Network Open
|
November 11, 2022
Comparison of Acupuncture vs Sham Acupuncture or Waiting List Control in the Treatment of Aromatase Inhibitor-Related Joint Pain: A Randomized Clinical Trial
Dawn L Hershman, Joseph M Unger, Heather Greenlee, et al.
In Vivo (Athens, Greece)
|
December 28, 2000
Tumor blood supply and tumor localization by adoptively transferred IL-2 activated natural killer cells
U Nannmark, M E Hokland, R Agger, et al.
Page
of 61